Abstract
Metabolism of 1,3-butadiene to 1,2-epoxybutene-3 in rats follows saturation kinetics. Comparative investigation of inhalation pharmacokinetics in mice also revealed a saturation pattern. For both species “linear” pharmacokinetics apply at exposure concentrations below 1000 ppm 1,3-butadiene; saturation of butadiene metabolism is observed at atmospheric concentrations of about 2000 ppm.
For mice metabolic clearance per kg body weight in the lower concentration range where first order metabolism applies was 7300ml×h−1 (rat: 4500 ml×h−1). Maximal metabolic elimination rate (Vmax) was 400 μmol×h−1 ×kg−1 (rat: 220 μmol ×h−1×kg−1). This shows that 1,3-butadiene is metabolized by mice at higher rates compared to rats.
Based on these investigations, the metabolic elimination rates of butadiene in both species were calculated for the exposure concentrations applied in two inhalation bioassays with rats and with mice. The results show that the higher rate of butadiene metabolism in mice when compared to rats may only in part be responsible for the considerable difference in the susceptibility of both species to butadiene-induced carcinogenesis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Andersen ME (1981) Saturable metabolism and its relationship to toxicity. CRC Crit Rev Toxicol 10: 105–150
Bolt HM, Link B (1980) Zur Toxikologie von Perchloräthylen. Verh Dtsch Ges Arbeitsmed 20: 463–470
Bolt HM, Schmiedel G, Filser JG, Rolzhäuser HP, Lieser K, Wistuba D, Schurig V (1983) Biological activation of 1,3-butadiene to vinyl oxirane by rat liver microsomes and expiration of the reactive metabolite by exposed rats. J Cancer Res Clin Oncol 106: 112–116
Bolt HM, Filser JG, Störmer F (1984) Inhalation pharmacokinetics based on gas uptake studies V. Comparative pharmacokinetics of ethylene and 1,3-butadiene in rats. Arch Toxicol 55:213–218
Buchter A, Bolt HM, Filser JG, Goergens HW, Laib RJ, Bolt W (1978) Pharmakokinetik und Carcinogenese von Vinylchlorid. Arbeitsmedizinische Risikobeurteilung. Verh Dtsch Ges Arbeitsmed 18: 111–115
Filser JG, Bolt HM (1979) Pharmacokinetics of halogenated ethylenes in rats. Arch Toxicol 42: 123–136
Filser JG, Bolt HM (1981) Inhalation pharmacokinetics based on gas uptake studies I. Improvement of kinetic models. Arch Toxicol 47: 279–292
Filser JG, Bolt HM (1983) Inhalation pharmacokinetics based on gas uptake studies IV. The endogenous production of volatile compounds. Arch Toxicol 52: 123–133
Filser JG, Bolt HM (1984) Inhalation pharmacokinetics based on gas uptake studies VI. Comparative evaluation of ethylene oxide and butadiene monoxide as exhaled reactive metabolites of ethylene and 1,3-butadiene in rats. Arch Toxicol 55:219–223
Hazleton Laboratories Europe (1981) “1,3-butadiene. Inhalation teratogenicity study in the rat”, Final report and addendum No. 2788-522/3, Hazleton Labs., Harrowgate HG3 1 PY, England
Huff JE, Melnick RL, Solleveld HA, Haseman JK, Powers M, Miller RA (1985) Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science 227: 548–549
Kirk-Othmer Enzyclopedia of Chemical Technology (1979), Wiley, New York, ed. 3, vol. 4, pp 313–337
Malvoisin E, Lhoest G, Poncelet F, Roberfroid M, Mercier M (1979) Identification and quantitation of 1,2-epoxybutene-3 as the primary metabolite of 1,3-butadiene. J Chromatogr 178: 419–425
Malvoisin E, Mercier M, Roberfroid M (1982) Enzymic hydration of butadiene monoxide and its importance in the metabolism of butadiene. Adv Exp Med Biol 38A: 437–444
Malvoisin E, Roberfroid M (1982) Hepatic microsomal metabolism of 1,3-butadiene. Xenobiotica 12: 137–144
Phalen RF (1983) Animal models. In: Inhalation studies formation and techniques, CRC Press Inc., Florida, pp 211–241
Schmidt U, Loeser E (1985) Species differences in the formation of butadiene monoxide from 1,3-butadiene. Arch Toxicol 57:222–225
Schumann AM, Quast JF, Watanabe PG (1980) The pharmacokinetics and macromolecular interactions of perchlorethylene in mice and rats as related to oncogenicity. Toxicol Appl Pharmacol 55: 207–219
Van Duuren BL, Nelson N, Orris L, Palmes ED, Schmitt FL (1963) Carcinogenicity of epoxides, lactons and peroxy compounds. J Natl Cancer Inst 31: 41–55
Walker CH (1978) Species differences in microsomal monooxygenase activity and their relationship to biological half-lives. Drug Metab Rev 7: 295–323
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kreiling, R., Laib, R.J., Filser, J.G. et al. Species differences in butadiene metabolism between mice and rats evaluated by inhalation pharmacokinetics. Arch Toxicol 58, 235–238 (1986). https://doi.org/10.1007/BF00297112
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00297112